The Global OTC Pharmaceutical market is expected to grow at a CAGR of 6.5% in the first half of the forecast period. The Global OTC Pharmaceutical market is estimated at $127bn in 2016 and is dominated by the cough, cold and allergy segment which holds 23% share of the Global OTC Pharmaceutical market.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 177-page report you will receive 82 tables and 79 figures – all unavailable elsewhere.
The 177-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global OTC Pharmaceutical Market forecasts from 2017-2027
• This report breaks down the revenue forecast of the Global OTC Pharmaceutical market into these leading segments: • Analgesics • Cough, cold and allergy products • Dermatological products • Gastrointestinal products • Eye Care • Smoking Cessation Aids • Other products
Each submarket is further divided by region: North America, South America, Europe, Asia-Pacific and RoW
• This report provides individual revenue forecasts to 2027 for these regional and national markets: • North America: the US, Canada, Mexico • South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America • Europe: Germany, France, the UK, Spain, Italy, Rest of Europe • Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific • Rest of the World: Middle East, Africa, Other Countries
• Our study provides a SWOT analysis and Porter’s Five Forces analysis of the Global OTC Pharmaceutical market
• This report discusses the leading companies in the Global OTC Pharmaceutical market • Bayer AG • GlaxoSmithKline (GSK) Consumer Care • Perrigo Company PLC • Johnson & Johnson • Daiichi Sankyo Co., Ltd • Pfizer Inc. • Procter & Gamble • Sanofi S.A • Reckitt Benckiser Group PLC • Cipla, Inc.
Visiongain’s study is intended for anyone requiring commercial analyses for the Global OTC Pharmaceutical Market. You find data, trends and predictions.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 The OTC Pharmaceuticals Market Overview 1.2 Research Methodology 1.3 Global OTC Pharmaceutical Market Segmentation 1.4 Why You Should Read This Report 1.5 How this report delivers? 1.6 Key Questions Answered by This Analytical Report 1.7 Frequently Asked Questions (FAQ) 1.8 Who is This Report For? 1.9 Associated Visiongain Reports 1.10 About Visiongain
2. Introduction to OTC Pharmaceuticals 2.1 What Are OTC Pharmaceuticals? 2.2 Classification of OTC Pharmaceuticals 2.3 What are the Requirements for an OTC Pharmaceutical Drug? 2.4 OTC Switching 2.4.1 How Is a Drug Switched from Prescription to OTC? 2.5 Manufacturing and Distribution of OTC Pharmaceuticals 2.6 Regulation of OTC Pharmaceuticals 2.6.1 Regulation of OTC Pharmaceuticals in the US 2.6.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs 2.6.3 Regulation of OTC Pharmaceuticals in Europe 2.6.4 Regulation of OTC Pharmaceuticals in China 2.6.5 Regulation of OTC Pharmaceuticals in Others Countries
3. Global OTC Pharmaceutical Market Forecast 2017-2027 3.1 The Current State of the OTC Pharmaceutical Market
4. Global OTC Pharmaceutical Market by Product: Market Forecast 2017- 2027 4.1 Overview 4.2 Cough, Cold and Allergy 4.2.1 Anti-Allergy Products 4.3 Analgesics 4.3.1 Internal Analgesics 4.3.2 External Analgesics 4.4 Gastrointestinal 4.5 Dermatological 4.5.1 Minor Cuts and Wounds 4.5.2 Acne 4.5.3 Rashes, Itchy Skin, and Dermatitis/Eczema 4.5.4 Cold Sores 4.5.5 Warts 4.5.6 Fungal Skin Infections 4.5.7 Haemorrhoids 4.5.8 Other Dermatological Products 4.6 Eye Care 4.6.1 Dry Eye Syndrome 4.6.2 Bacterial Conjunctivitis 4.6.3 Ocular Allergy and Allergic Conjunctivitis 4.6.4 Treatment of Ocular Allergy/ Allergic Conjunctivitis 4.7 Smoking Cessation Aids 4.8 Other Products
5. Global OTC Pharmaceutical Market by National Market: Market Forecast 2017- 2027 5.1 Global OTC Pharmaceuticals Market: Regional Forecast, 2017-2027 5.2 North American OTC Pharmaceutical Market Forecasts 2017-2027 5.2.1 USA OTC Pharmaceutical Market Forecasts 2017-2027 5.2.2 Canada OTC Pharmaceutical Market Forecasts 2017-2027 5.2.3 Mexico OTC Pharmaceutical Market Forecasts 2017-2027 5.3 South American OTC Pharmaceutical Market Forecasts 2017-2027 5.3.1 Brazil OTC Pharmaceutical Market Forecasts 2017-2027 5.3.2 Argentina OTC Pharmaceutical Market Forecasts 2017-2027 5.3.3 Paraguay OTC Pharmaceutical Market Forecasts 2017-2027 5.3.4 Bolivia OTC Pharmaceutical Market Forecasts 2017-2027 5.3.5 Rest of South America OTC Pharmaceutical Market Forecasts 2017-2027 5.4 European OTC Pharmaceutical Market Forecasts 2017-2027 5.4.1 France OTC Pharmaceutical Market Forecasts 2017-2027 5.4.2 Germany OTC Pharmaceutical Market Forecasts 2017-2027 5.4.3 UK OTC Pharmaceutical Market Forecasts 2017-2027 5.4.4 Spain OTC Pharmaceutical Market Forecasts 2017-2027 5.4.5 Italy OTC Pharmaceutical Market Forecasts 2017-2027 5.4.6 Rest of Europe OTC Pharmaceutical Market Forecasts 2017-2027 5.5 Asia-Pacific OTC Pharmaceutical Market Forecasts 2017-2027 5.5.1 China OTC Pharmaceutical Market Forecasts 2017-2027 5.5.2 Japan OTC Pharmaceutical Market Forecasts 2017-2027 5.5.3 India OTC Pharmaceutical Market Forecasts 2017-2027 5.5.4 Australia OTC Pharmaceutical Market Forecasts 2017-2027 5.5.5 Thailand OTC Pharmaceutical Market Forecasts 2017-2027 5.5.6 Rest of Asia-Pacific OTC Pharmaceutical Market Forecasts 2017-2027 5.6 Rest of World OTC Pharmaceutical Market Forecasts 2017-2027 5.6.1 Middle East OTC Pharmaceutical Market Forecasts 2017-2027 5.6.2 Africa OTC Pharmaceutical Market Forecasts 2017-2027 5.6.3 Other Countries OTC Pharmaceutical Market Forecasts 2017-2027
6. Qualitative Analysis of the OTC Pharmaceutical Market, 2017-2027 6.1 SWOT Analysis of the OTC Pharmaceutical Market 6.2 Strengths 6.2.1 Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption 6.2.1.1 Manufacturers Can Reap OTC Sales Benefits 6.2.1.2 Third Party Payers: Reducing the Cost Burden 6.2.1.3 Healthcare Systems: Pushing the Cost to the Consumer 6.2.2 Many Pharmaceutical Companies Have a Strong Potential OTC Portfolio 6.2.3 Regulators Are Encouraging OTC Approvals 6.2.4 Effective Distribution Networks Due to Expansion of Retail Pharmacy and Alternative Distributors 6.2.5 Deterring the Consumption of Counterfeit Drugs 6.2.6 Cultural Changes Will Support Self-Medication with OTC Medicines 6.3 Weaknesses 6.3.1 Pharma Companies Remain Focused on Prescription Drugs 6.3.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs 6.3.3 OTC Products are Vulnerable to Price Controls by Governments 6.3.4 Downward Cost Pressures of OTC Drugs 6.4 Opportunities 6.4.1 Demographic and Economic Changes Will Create Growth Opportunities 6.4.2 New OTC Switch Categories 6.4.3 Strong Growth in Emerging Markets 6.4.4 New Healthcare Technologies May enable OTC Approvals 6.4.5 Opportunities to Drive Sales via Social Media and Online Marketing 6.4.6 Self-Medication Can Reduce the Under Treatment of Disease 6.5 Threats 6.5.1 Competition from Private-Label Brands Will Reduce Profitability 6.5.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products 6.5.3 Resistance to OTC Switching from Some Groups in Certain Countries 6.6 Porter’s Five Forces Analysis of the OTC Pharmaceutical Market 6.6.1 Rivalry Among Competitors [High] 6.6.2 Threat of New Entrants [Medium] 6.6.3 Power of Suppliers [Low] 6.6.4 Power of Buyers [Medium] 6.6.5 Threats of Substitutes [Medium]
7. Leading Companies in the OTC Pharmaceutical Market 7.1 Bayer AG 7.1.1 Bayer AG: Company Overview 7.1.2 Bayer AG: Product Portfolio 7.1.3 Bayer AG: Recent Developments 7.2 GlaxoSmithKline PLC (GSK Consumer Care) 7.2.1 GlaxoSmithKline PLC: Company Overview 7.2.2 GlaxoSmithKline PLC: Product Portfolio 7.2.3 GlaxoSmithKline PLC: Recent Developments 7.3 Johnson & Johnson 7.3.1 Johnson & Johnson: Company Overview 7.3.2 Johnson & Johnson: Product Portfolio 7.3.3 Johnson & Johnson: Recent Developments 7.4 Perrigo Company PLC 7.4.1 Perrigo Company PLC: Company Overview 7.4.2 Perrigo Company PLC: Product Portfolio 7.4.3 Perrigo Company PLC: Recent Developments 7.5 Daiichi Sankyo Co., Ltd. 7.5.1 Daiichi Sankyo Co., Ltd.: Company Overview 7.5.2 Daiichi Sankyo Co., Ltd.: Recent Developments 7.6 Pfizer Inc. 7.6.1 Pfizer Inc.: Company Overview 7.6.2 Pfizer Inc.: Product Portfolio 7.6.3 Pfizer Inc.: Recent Developments 7.7 Procter & Gamble 7.7.1 Procter & Gamble: Company Overview 7.7.2 Procter & Gamble: Product Portfolio 7.7.3 Procter & Gamble: Recent Developments 7.8 Sanofi S.A. 7.8.1 Sanofi S.A.: Company Overview 7.8.2 Sanofi S.A.: Product Portfolio 7.8.3 Sanofi S.A: Recent Developments 7.9 Reckitt Benckiser Group PLC 7.9.1 Reckitt Benckiser Group PLC: Company Overview 7.9.2 Reckitt Benckiser Group PLC: Product Portfolio 7.9.3 Reckitt Benckiser Group PLC: Recent Developments 7.10 Cipla Inc. 7.10.1 Cipla Inc.: Company Overview 7.10.2 Cipla Inc.: Product Portfolio 7.10.3 Cipla Inc.: Recent Developments
8. Conclusions 8.1 The World OTC Pharmaceutical Market in 2016-2017 8.1.1 The Leading OTC Product Categories 8.1.2 Leading National Markets: Emerging Market Represent a Large Proportion 8.1.3 The Global OTC Market Growth Factors 8.1.4 Potential OTC Switching, 2017-2027 8.1.5 Emerging OTC Markets 8.2 Concluding Remarks
Appendices Associated Visiongain Reports Visiongain Report Sales Order Form Appendix A About Visiongain Appendix B Visiongain report evaluation form
List of Tables Table 3.1 Global OTC Pharmaceutical Market Forecast ($bn, AGR%, CAGR%) 2017-2027 Table 4.1 Global OTC Pharmaceutical Market Forecast, by Product ($bn, AGR%) 2017-2027 Table 4.2 OTC Cough, Cold and Allergy Active Ingredients, 2017 Table 4.3 Global OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, ($bn, AGR%) 2017-2027 Table 4.4 OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn, AGR%) 2017-2027 Table 4.5 OTC Internal Analgesic Active Ingredients, 2017 Table 4.6 OTC External Analgesic Active Ingredients, 2017 Table 4.7 Global OTC Pharmaceutical Market for Analgesics Market Forecast, ($bn, AGR%) 2017-2027 Table 4.8 OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn, AGR%) 2017-2027 Table 4.9 Global OTC Pharmaceutical Market for Gastrointestinal Market Forecast, ($bn, AGR%) 2017-2027 Table 4.10 OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography ($bn, AGR%) 2017-2027 Table 4.11 OTC Antifungal Active Ingredients, 2017 Table 4.12 Global OTC Pharmaceutical Market for Dermatological Market Forecast, ($bn, AGR%) 2017-2027 Table 4.13 OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn, AGR%) 2017-2027 Table 4.14 OTC Dry Eye Syndrome Active Ingredients, 2017 Table 4.15 OTC Bacterial Conjunctivitis Active Ingredients, 2017 Table 4.16 OTC Ocular Allergy Active Ingredients, 2017 Table 4.17 Global OTC Pharmaceutical Market for Eye Care Market Forecast, ($bn, AGR%) 2017-2027 Table 4.18 OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography ($bn, AGR%) 2017-2027 Table 4.19 OTC Smoking Cessation Aid Active Ingredients, 2017 Table 4.20 Global OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, ($bn, AGR%) 2017-2027 Table 4.21 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography ($bn, AGR%) 2017-2027 Table 4.22 Global OTC Pharmaceutical Market for Other Products Market Forecast, ($bn, AGR%) 2017-2027 Table 4.23 OTC Pharmaceutical Market for Other Products Market Forecast,by Geography ($bn, AGR%) 2017-2027 Table 5.1 OTC Pharmaceutical Market Forecast, by Geography ($bn, AGR%) 2017-2027 Table 5.2 North America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027 Table 5.3 USA OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.4 Canada OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.5 Mexico OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.6 South America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027 Table 5.7 Brazil OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.8 Argentina OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.9 Paraguay OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.10 Bolivia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.11 Rest of South America OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.12 European OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027 Table 5.13 France OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.14 Germany OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.15 UK OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.16 Spain OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.17 Italy OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.18 Rest of European OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.19 Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027 Table 5.20 China OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.21 Selected Leading Companies in the Japanese OTC Pharma Market, 2017 Table 5.22 Japan OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.23 India OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.24 Australia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.25 Thailand OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.26 Rest of Asia-Pacific OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.27 Rest of World OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027 Table 5.28 Middle East OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.29 Africa OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 5.30 Other Countries OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027 Table 7.1 Bayer AG: Company Overview Table 7.2 Bayer AG: Product Portfolio Table 7.4 GlaxoSmithKline PLC: Company Overview Table 7.5 GlaxoSmithKline PLC: Product Portfolio Table 7.6 GlaxoSmithKline PLC: Recent Developments Table 7.7 Johnson & Johnson: Company Overview Table 7.8 Johnson & Johnson: Product Portfolio Table 7.9 Johnson & Johnson: Recent Developments Table 7.10 Perrigo Company PLC: Company Overview Table 7.11 Perrigo Company PLC: Product Portfolio Table 7.12 Perrigo Company PLC: Recent Developments Table7.13 Daiichi Sankyo Co., Ltd.: Company Overview Table 7.14 Daiichi Sankyo Co., Ltd.: Recent Developments Table 7.15 Pfizer Inc.: Company Overview Table 7.16 Pfizer Inc.: Product Portfolio Table 7.17 Pfizer Inc.: Recent Developments Table 7.18 Procter & Gamble: Company Overview Table 7.19 Procter & Gamble: Product Portfolio Table 7.20 Procter & Gamble: Recent Developments Table 7.21 Sanofi S.A.: Company Overview Table 7.22 Sanofi S.A.: Product Portfolio Table 7.23 Sanofi S.A: Recent Developments Table 7.24 Reckitt Benckiser Group PLC: Company Overview Table 7.25 Reckitt Benckiser Group PLC: Product Portfolio Table 7.26 Reckitt Benckiser Group PLC: Recent Developments Table 7.27 Cipla Inc.: Company Overview Table 7.28 Cipla Inc.: Product Portfolio Table 7.29 Cipla Inc.: Recent Developments
List of Figures Figure 1.1 OTC Pharmaceuticals: Overview of Submarkets Figure 2.1 The OTC Pharmaceutical Supply Chain, 2017 Figure 3.1 OTC Pharmaceutical Market, by Product, ($bn), 2017-2027 Figure 3.2 OTC Pharmaceutical Market, by Geography, ($bn), 2017-2027 Figure 4.1 OTC Pharmaceutical Market, by Product, Market Share (%), 2016 Figure 4.2 OTC Pharmaceutical Market, by Product, Forecast ($bn) 2017-2027 Figure 4.3 OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn) 2017-2027 Figure 4.4 OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn) 2017-2027 Figure 4.5 OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography, ($bn) 2017-2027 Figure 4.6 OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn) 2017-2027 Figure 4.7 OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography($bn) 2017-2027 Figure 4.8 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography, ($bn) 2017-2027 Figure 4.9 OTC Pharmaceutical Market for Other Products Market Forecast, by Geography($bn) 2017-2027 Figure 5.1 OTC Pharmaceutical Market Forecast, by Geography ($bn) 2017-2027 Figure 5.2 Global OTC Pharmaceutical Market, by Geography, Market Share (%), 2016 Figure 5.3 North America OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027 Figure 5.4 North America OTC Pharmaceutical Market, by Country, Market Share (%), 2016 Figure 5.5 USA OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.6 Canada OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.7 Mexico OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.8 South America OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027 Figure 5.9 South America OTC Pharmaceutical Market, by Country, Market Share (%), 2016 Figure 5.10 Brazil OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.11 Argentina OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.12 Paraguay OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.13 Bolivia OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.14 Rest of South America OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.15 Europe OTC Pharmaceutical Market Forecast, by Country($bn) 2017-2027 Figure 5.16 Europe OTC Pharmaceutical Market, by Country, Market Share (%), 2016 Figure 5.17 France OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.18 Germany OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.19 UK OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.20 Spain OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.21 Italy OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.22 Rest of Europe OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.23 Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($billion) 2017-2027 Figure 5.24 Asia-Pacific OTC Pharmaceutical Market, by Country, Market Share (%), 2016 Figure 5.25 China OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.26 Japan OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.27 India OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.28 Australia OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.29 Thailand OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.30 Rest of Asia-Pacific OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.31 RoW OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027 Figure 5.32 Rest of World OTC Pharmaceutical Market, by Country, Market Share (%), 2016 Figure 5.33 Middle East OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.34 Africa OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 5.35 Other Countries OTC Pharmaceutical Market Forecast ($bn) 2017-2027 Figure 6.1 Porter’s Five Analysis of the OTC Pharmaceutical Market, 2017 Figure 7.1 Bayer AG, Revenue, ($million), 2012-2016 Figure 7.2 Bayer AG, Product Segments Share (%), 2016 Figure 7.3 Bayer AG, Geographic Presence Share (%), 2016 Figure 7.4 GlaxoSmithKline PLC, Revenue, ($million), 2012-2016 Figure 7.5 GlaxoSmithKline PLC, Product Segments Share (%), 2016 Figure 7.6 GlaxoSmithKline PLC, Geographical Presence Share (%), 2016 Figure 7.7 Johnson & Johnson, Revenue, ($million), 2012-2016 Figure 7.8 Johnson & Johnson, Product Segments Share (%), 2016 Figure 7.9 Johnson & Johnson, Geographical Presence Share (%), 2016 Figure 7.10 Perrigo Company PLC, Revenue, ($million), 2012-2016 Figure 7.11 Perrigo Company PLC, Product Segments Share (%), 2016 Figure 7.12 Perrigo Company PLC, Geographical Presence Share (%), 2016 Figure 7.13 Daiichi Sankyo Co., Ltd., Revenue, ($million), 2012-2016 Figure 7.14 Daiichi Sankyo Co., Ltd., Product Segments Share (%), 2016 Figure 7.15 Daiichi Sankyo Co., Ltd., Geographical Presence Share (%), 2016 Figure 7.16 Pfizer Inc., Revenue, ($million), 2012-2016 Figure 7.17 Pfizer Inc., Product Segments Share (%), 2016 Figure 7.18 Pfizer Inc., Geographical Presence Share (%), 2016 Figure 7.19 Procter & Gamble, Revenue, ($million), 2012-2016 Figure 7.20 Procter & Gamble, Product Segments Share (%), 2016 Figure 7.21 Procter & Gamble, Geographical Presence Share (%), 2016 Figure 7.22 Sanofi S.A., Revenue, ($million), 2012-2016 Figure 7.23 Sanofi S.A., Product Segments Share (%), 2016 Figure 7.24 Sanofi S.A., Geographical Presence Share (%), 2016 Figure 7.25 Reckitt Benckiser Group PLC, Revenue, ($million), 2012-2016 Figure 7.26 Reckitt Benckiser Group PLC, Product Segments Share (%), 2016 Figure 7.27 Cipla Inc., Revenue, ($million), 2012-2016 Figure 7.28 Cipla Inc., Product Segments Share (%), 2016 Figure 8.1 Global OTC Pharmaceutical Market Revenue, by Product Type ($bn), 2017-2027 Figure 8.2 Global OTC Pharmaceutical Market Revenue, by Geography ($bn), 2017-2027
Abbott Medical Optics Aché Laboratórios Farmacêuticos Actavis Adams Respiratory Therapeutics Akorn Alcon Allergan Alliance Boots Almirall Amerisource Bergen ANVISA Apotex Arena Pharmaceuticals Aspen Pharmacare Astellas Pharma AstraZeneca Aurobindo B.F. Ascher & Company Bausch & Lomb Bayer Boehringer Ingelheim Boots Bristol-Myers Squibb Cardinal Health Celesio China Resources Sanjiu Pharmaceutical Ciba Cilag Cipla Costco CSPC (China Shijiazhuang Pharmaceutical Group) CVS Daiichi Sankyo Dalkhimpharm Dollar General Dr. Reddy’s Laboratories Eisai Eli Lilly EMS Eurofarma Fosun Pharma Galderma Genomma Lab GSK Guangzhou Pharmaceutical Harbin Pharmaceutical Group Heritage/Insight Hisamitsu Hypermacas Im Co., Ltd. Insight Ipca Laboratories JB Chemicals Johnson & Johnson Kangmei Pharmaceutical Kowa Kroger Lion LOréal Lupin Limited Mankind Pharma McKesson Mead Johnson Menarini Merck Mylan North China Pharmaceutical Novartis Nycomed Omega Pharma Otsuka Paras Pharmaceuticals Perrigo Pfizer Pharmstandard Phoenix Prestige Brands Procter & Gamble Purdue Pharma Ranbaxy Ratiopharm Reckitt Benckiser Roche Rohto Roxane Labs Sam’s Club Sandoz Sanofi Sato Sergeant Shanghai Pharmaceuticals Shionogi Sinopharm SkyePharma Somaxon Pharmaceuticals Sotex SSL International Stada Sun Pharma Taisho Takeda Teva Torrent Pharmaceuticals Typharm UCB Pharma União Química Valeant Velcera Veropharm Vivus
Organizations Mentioned in the Report Association of the European Self-Medication Industry (AESGP) National Pharmaceutical Pricing Authority (NPPA) The Brazilian Health Surveillance Agency The European Medicines Agency (EMA) The Food and Drug Administration (FDA) The General Directorate of Pharmaceuticals and Pharmacy (IEGM) (Turkey) The Medicines and Healthcare products Regulatory Agency (MHRA) The Ministry of Health, Labour and Welfare (MHLW) The Pharmaceutical and Medical Devices Agency (PMDA)
Download sample pages
Complete the form below to download your free sample pages for Global OTC Pharmaceutical Market Forecast 2017-2027
Download sample pages
Complete the form below to download your free sample pages for Global OTC Pharmaceutical Market Forecast 2017-2027
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
